SHE:301509 - Kingchem (Liaoning) Life Science Co Ltd

Kingchem (Liaoning) Life Scien
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q4	2020 Q4	2021 Q2	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	-	15.4% -	21.5% 39.7%	22.04% 2.5%	28.8% 30.6%	22.53% -21.8%	21.76% -3.4%	22.42% 3.0%	20.73% -7.6%	22.64% 9.2%	22.1% -2.4%
Gross Margin	[friend]	[friend]	[friend]	-	40.15% -	46.83% 16.6%	44% -6.0%	44.93% 2.1%	44.11% -1.8%	42.95% -2.6%	44.81% 4.3%	46.46% 3.7%	47.2% 1.6%	47.45% 0.5%
Operating Margin	[friend]	[friend]	[friend]	-	20.43% -	26.47% 29.5%	27.83% 5.1%	25.78% -7.3%	25.39% -1.5%	25.13% -1.0%	24.81% -1.3%	24.45% -1.5%	27.34% 11.8%	24.76% -9.4%
Total Revenue	[friend]	[friend]	[friend]	254.56M -	549.19M 115.7%	154.45M -71.9%	669.53M 333.5%	191.95M -71.3%	716.67M 273.4%	776.1M 8.3%	773.8M -0.3%	735.89M -4.9%	766.82M 4.2%	677.27M -11.7%
Total Assets	[friend]	[friend]	[friend]	860.48M -	897.51M 4.3%	-	1.07B -	-	1.21B -	1.13B -7.0%	1.23B 9.2%	2.42B 97.1%	2.31B -4.5%	2.3B -0.7%
Total Liabilities	[friend]	[friend]	[friend]	205.23M -	193.71M -5.6%	-	262.86M -	-	331.21M -	206.35M -37.7%	229.09M 11.0%	275.94M 20.4%	139.63M -49.4%	105.69M -24.3%
Total Equity	[friend]	[friend]	[friend]	655.26M -	703.8M 7.4%	-	811.36M -	-	878.79M -	918.83M 4.6%	999.26M 8.8%	2.14B 114.6%	2.17B 1.2%	2.19B 0.8%
Operating CashFlow	[friend]	[friend]	[friend]	16.52M -84.4%	72.27M 337.5%	-	104.5M -	-	241.55M -	-	167.43M -	-	155.16M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	268.71M 232.8%	268.71M 0%	181.05M -32.6%	238.16M 31.5%	289.3M 21.5%	181.05M -37.4%	238.16M 31.5%	289.3M 21.5%	360.49M 24.6%	231.01M -35.9%	223.45M -3.3%
End Cash Position	[friend]	[friend]	[friend]	213.78M -20.4%	181.05M -15.3%	238.16M 31.5%	289.3M 21.5%	360.49M 24.6%	231.01M -35.9%	213.74M -7.5%	254.05M 18.9%	1.46B 473.8%	486.9M -66.6%	532.62M 9.4%
Free Cash Flow	[friend]	[friend]	[friend]	16.52M -13.7%	-98.39M -	11.92M -	-10.41M -	59.1M -	114.86M 94.4%	58.73M -48.9%	67.74M 15.3%	116.01M 71.3%	82.26M -29.1%	185.27M 125.2%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	36.82M -37.5%	84.55M 129.6%	-	99.86M -	-	161.45M -	-	173.49M -	-	173.57M -	-
Diluted Net Income	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	0.571 -	1.32 131.3%	0.51 -61.4%	2.297 350.4%	0.85 -63.0%	2.5 194.1%	1.871 -25.1%	1.917 2.4%	1.632 -14.9%	1.729 5.9%	1.414 -18.2%
Return On Equity (%)	[friend]	[friend]	[friend]	-	13.86% -	-	20.13% -	-	20.4% -	18.38% -9.9%	19.16% 4.2%	7.11% -62.9%	11.38% 60.0%	9.63% -15.4%
Return On Assets (%)	[friend]	[friend]	[friend]	-	10.09% -	-	15.26% -	-	15.32% -	15.01% -2.0%	15.07% 0.4%	6.3% -58.2%	9.86% 56.5%	8.75% -11.3%